Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?

被引:254
|
作者
Shah, Shailja C. [1 ]
Kayamba, Violet [2 ]
Peek, Richard M., Jr. [1 ]
Heimburger, Douglas [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, 2215 Garland Ave,MRB 4,1030-C, Nashville, TN 37203 USA
[2] Univ Zambia, Sch Med, Lusaka, Zambia
来源
JOURNAL OF GLOBAL ONCOLOGY | 2019年 / 5卷
关键词
GLOBAL BURDEN; CERVICAL-CANCER; HEALTH; INFECTIONS; MORTALITY;
D O I
10.1200/JGO.18.00200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The rising prevalence of noncommunicable diseases globally, with a strikingly disproportionate increase in prevalence and related mortality in low- and middle-income countries (LMICs), is a major threat to sustainable development. The epidemiologic trend of cancers in LMICs is of particular concern. Despite a lower incidence of cancer in LMICs compared with high-income countries, total cancer-related mortality is significantly higher in LMICs, especially in people younger than 65 years of age. The enormous economic impact of premature mortality and lost productive life years highlights the critical importance of galvanizing cancer prevention and management to achieve sustainable development. The rising burden of cancer in LMICs stresses an already weak health care and economic infrastructure and poses unique challenges. Although the WHO acknowledges that the effective management of cancer relies on early detection, accurate diagnosis, and access to appropriate multimodal therapy, the placement of priority on early detection cannot be assumed to be effective in LMICs, where limited downstream resources may be overwhelmed by the inevitable increases in number of diagnoses. This review discusses several factors and considerations that may compromise the success of cancer control programs in LMICs, particularly if the focus is only on early detection through screening and surveillance. It is intended to guide optimal implementation of cancer control programs by accentuating challenges common in LMICs and by emphasizing the importance of cancer prevention where relevant so that communities and stakeholders can work together to devise optimal means of combatting the growing burden of cancer. (C) 2019 by American Society of Clinical Oncology
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Improving Cancer Outcomes In Low- and Middle-Income Countries
    Love, Richard R.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5
  • [22] Access to cancer medications in low- and middle-income countries
    Gilberto de Lima Lopes
    Jonas A. de Souza
    Carlos Barrios
    Nature Reviews Clinical Oncology, 2013, 10 : 314 - 322
  • [23] Cervical Cancer Prevention in Low- and Middle-Income Countries
    Allanson, Emma R.
    Schmeler, Kathleen M.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2021, 64 (03): : 501 - 518
  • [24] Childhood cancer surgery in low- and middle-income countries
    Pio, Luca
    Loh, Amos
    Harrison, Derek
    Gonzalez, Gloria
    Qureshi, Sajid
    Lakhoo, Kokila
    Abib, Simone
    Abdelhafeez, Abdelhafeez H.
    PEDIATRIC BLOOD & CANCER, 2024,
  • [25] Frailty Screening in Low- and Middle-Income Countries: A Systematic Review
    Gray, William K.
    Richardson, Jenny
    McGuire, Jackie
    Dewhurst, Felicity
    Elder, Vasanthi
    Weeks, Julie
    Walker, Richard W.
    Dotchin, Catherine L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (04) : 806 - 823
  • [26] PISA for low- and middle-income countries
    Bloem, Simone
    COMPARE-A JOURNAL OF COMPARATIVE AND INTERNATIONAL EDUCATION, 2015, 45 (03) : 481 - 486
  • [27] Orthopaedics in low- and middle-income countries
    Andrew Quaile
    International Orthopaedics, 2022, 46 : 1 - 1
  • [28] Hypertension in Low- and Middle-Income Countries
    Schutte, Aletta E.
    Venkateshmurthy, Nikhil Srinivasapura
    Mohan, Sailesh
    Prabhakaran, Dorairaj
    CIRCULATION RESEARCH, 2021, 128 (07) : 808 - 826
  • [29] Orthopaedics in low- and middle-income countries
    Quaile, Andrew
    INTERNATIONAL ORTHOPAEDICS, 2022, 46 (01) : 1 - 1
  • [30] Epilepsy in low- to middle-income countries
    Sen, Arjune
    Newton, Charles R.
    Ngwende, Gift
    CURRENT OPINION IN NEUROLOGY, 2025, 38 (02) : 121 - 127